While there's a lot of enthusiasm for personalized medicine, making sense of what gene variants mean in terms of disease risk is still a work in progress. At the Washington Post, Carolyn Johnson writes that there's currently "a very long list of genes for which the best medical understanding of what they mean for our health is essentially a shrug."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.